Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2010
06/23/2010CN101744792A Fluticasone propionate and salmeterol xinafoate compound dry powder inhalation and preparation technology thereof
06/23/2010CN101744367A Skimmia japonica cigarette and manufacture process thereof
06/23/2010CN101744233A Isatis root cold tea
06/23/2010CN101743963A Mosquito repellent and preparation method thereof
06/23/2010CN101292952B Glycyrrhizic acid, biogastrone acid or its salt, derivative temperature sensing gel rubber, preparation method and application thereof
06/23/2010CN101269201B Chinese medicine compound percutaneous absorption patch for treating menorrhalgia and preparation method thereof
06/23/2010CN101249203B Traditional Chinese medicine for curing acute and chronic waist-leg pain and lumbar intervertebral disc bulge bone fracture dislocation
06/23/2010CN101229313B Hotspring powder medicine compounds
06/23/2010CN101199601B Naze rheumatism medicated liquor
06/23/2010CN101156920B Oral administration and externally used drug for treating traumatic injury and its preparation method
06/23/2010CN101156901B An externally used traditional Chinese medicine preparation for treating rheumatism and rheumatoid as well as its preparation method
06/23/2010CN101104015B Olive soft capsule raw material formulation and its preparation technology
06/23/2010CN101100689B Method for preparing pearl active peptide
06/22/2010US7741372 Targeting p38 mitogen activated protein kinase (MAPK) cellular signaling pathway; using such as N,N'-bis(3,5-diacetylphenyl)decanediamide tetrakis(amidinohydrazone) tetrahydrochloride
06/22/2010US7741359 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
06/22/2010US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation
06/22/2010US7741335 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741292 Method of inhibiting the emigration of cells from the intravascular compartment into tissues
06/22/2010US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741056 Junctional Adhesion Molecule (JAM); treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer; antagonist of a native sequence STIgMA polypeptide
06/22/2010US7741047 Using histone binding protein (RBAp48) as evaluative tool in identifying modulators for treatment of sjogren's syndrome
06/22/2010US7741030 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2552218C Left-side glucose lipid a analogue
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2469225C Citric acid salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one and pharmaceutical compositions thereof
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2443633C Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
06/22/2010CA2439430C Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/22/2010CA2410408C 2-aminoalkylthieno[2,3-d]pyrimidines
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/22/2010CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/22/2010CA2190943C Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
06/17/2010WO2010068863A2 Pyrimidine compounds and methods of making and using same
06/17/2010WO2010068810A2 Certain substituted amides, method of making, and method of use thereof
06/17/2010WO2010068788A1 Heterocyclic amides as btk inhibitors
06/17/2010WO2010068520A2 Substituted imidazoheterocycle derivatives
06/17/2010WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010068452A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010067130A1 P38 map kinase inhibitors
06/17/2010WO2010067101A1 Dihydroetorphines and their preparation
06/17/2010WO2010067010A2 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010WO2010067007A2 Synthesis of morphine-6-glucuronide or one of the derivatives thereof
06/17/2010WO2010066931A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
06/17/2010WO2010066840A1 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
06/17/2010WO2010066239A1 Inhibitors of dimethylarginine dimethylaminohydrolase
06/17/2010WO2010066125A1 A short peptide, preparation and uses thereof
06/17/2010WO2010066100A1 The 2-oxo-1,3-oxaazocyclopentane-4-formamide derivatives and their uses as the immunosuppressant.
06/17/2010WO2010065995A1 Isolated vegf-c and vegf-d peptides and uses thereof
06/17/2010WO2010033392A3 Methods and kits for treating cluster headache disorders
06/17/2010WO2010022043A3 Targeting of histone deacetylase 2 and protein kinase ck2 for treatment of inflammatory diseases
06/17/2010WO2008050199A3 Substituted phenylmethyl bicyclocarboxyamide compounds
06/17/2010US20100152446 Piperidine Derivatives
06/17/2010US20100152305 Methods of treatment of hyperuricemia and associated disease states
06/17/2010US20100152304 Pharmaceutical composition comprising periplaneta americana or its ethanol extract and a method of using the same for treating inflammations
06/17/2010US20100152296 Photopolymerization material for gums isolation
06/17/2010US20100152274 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
06/17/2010US20100152255 Organic Compounds
06/17/2010US20100152252 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
06/17/2010US20100152251 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
06/17/2010US20100152241 Inhibitors of store operated calcium release
06/17/2010US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
06/17/2010US20100152239 Method to Improve Survival in Sepsis
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152209 Compounds for Modulating TRPV3 Function
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152173 Tablet Having Improved Stability With At Least Two Actives
06/17/2010US20100152172 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
06/17/2010US20100152169 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152160 Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
06/17/2010US20100152158 Substituted Disulfonamide Compounds
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152151 Tgr5 modulators and methods of use therof
06/17/2010US20100152127 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
06/17/2010US20100152113 Metal-binding therapeutic peptides
06/17/2010US20100151507 Cavity Induced Allosteric Modification Of Intermolecular Interactions And Methods Of Identifying Compounds That Effect The Same
06/17/2010US20100151032 Silver and Zinc Containing Body Care Agent
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100150950 Human antibodies that bind cd70 and uses thereof
06/17/2010US20100150938 Methods and compositions for reducing inflammation and treating inflammatory disorders
06/17/2010US20100150916 huTNFR1 Selective Antagonists
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2
06/17/2010US20100150868 Methods of Individually Optimizing Treatment for an Inflammation Associated Disease
06/17/2010US20100150865 Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases
06/17/2010CA2746429A1 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2746428A1 Synthesis of morphine-6-glucuronide or one of the derivatives thereof
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 1272